Copy link
Export CSV
Cite this view
HANK Price Transparency. (n.d.).
Faricimab Ophthalmic Svoa 6 Mg/0.05 Ml Sol (CDM 4083041) by State .
PPMan price-transparency data, derived from CMS-required hospital MRFs.
Retrieved October 8, 2026 , from http://ppman.hank.ai/transparency/procedure/4083041/by-state?code_type=CDM
“Faricimab Ophthalmic Svoa 6 Mg/0.05 Ml Sol (CDM 4083041) by State.” HANK Price Transparency ,
http://ppman.hank.ai/transparency/procedure/4083041/by-state?code_type=CDM. Accessed
October 8, 2026 .
“Faricimab Ophthalmic Svoa 6 Mg/0.05 Ml Sol (CDM 4083041) by State,” HANK Price Transparency ,
accessed October 8, 2026 ,
http://ppman.hank.ai/transparency/procedure/4083041/by-state?code_type=CDM.
Source: PPMan price-transparency data, derived from CMS-required hospital
machine-readable files (45 CFR 180). See
methodology .
Print / Save PDF
CDM · across United States
4083041 — Faricimab Ophthalmic Svoa 6 Mg/0.05 Ml Sol
State-by-state median negotiated rates. Lower bars are cheaper states; the
range bar shows the IQR (25th to 75th percentile within each state).
$2,640
National median
$1,810 – $3,096
IQR (p25 – p75)
1
hospitals filing
1
states
Median negotiated rate, by state
Ranked by typical (median) negotiated price. Hover for state-level IQR.
Median negotiated rate by state for 4083041 (CDM), with interquartile range
State Median p25 p75
ND $2,640 $1,810 $3,096